Tudorza Pressair (aclindinium recalls

The FDA has published 1 recall involving Tudorza Pressair (aclindinium since 2016. The latest was reported on 30 Mar 2016. Recalls usually affect specific lots, not every bottle on the market. Check the lot number on each recall page before acting.

Total recalls1since 2016

Last 12 months0reported

Class I00% of total

Ongoing0latest 30 Mar 2016

Recalls per month, last 24 months

click a bar for that month

0Oct '24 0 0 0Jan '25 0 0 0Apr 0 0 0Jul 0 0 0Oct 0 0 0Jan '26 0 0 0Apr 0 0 0Jul 0 0

Severity split

Class I 0 0%Class II 1 100%Class III 0 0%

Why tudorza pressair (aclindinium is recalled

Other Reasons1100%

Companies

AstraZeneca Pharmaceuticals1100%

By year

20161100%

All tudorza pressair (aclindinium recalls, newest first

1 total

Reported	Class	Recall	Company	Reason	Where
30 Mar 2016Drug	CLASS II	Tudorza Pressair (aclindinium bromide inhalation powder) recalled	AstraZeneca Pharmaceuticals	Other	Nationwide

Should you stop taking Tudorza Pressair (aclindinium?

Not on your own. Most recalls affect specific lots from one manufacturer, and stopping a prescription suddenly can be riskier than the defect. Check your lot number and NDC against the recall, then call the pharmacy that dispensed it for a replacement.